Resources Contact Us Home
A.sub.3 adenosine receptor agonists

Image Number 13 for United States Patent #5688774.

The present invention provides A.sub.3 selective agonists, particularly, adenine compounds having selected substituents at the 2, 6, and 9 positions, and related substituted compounds, particularly those containing substituents on the benzyl and/or uronamide groups, as well as pharmaceutical compositions containing such compounds. The present invention also provides a method of selectively activating an A.sub.3 adenosine receptor in a mammal, which method comprises acutely or chronically administering to a mammal in need of selective activation of its A.sub.3 adenosine receptor a therapeutically or prophylactically effective amount of a compound which binds with the A.sub.3 receptor so as to stimulate an A.sub.3 receptor-dependent response.

  Recently Added Patents
Autonomous primary-mirror synchronized reset
Apparatus for touch screen avionic device
System and method for enhanced artificial bandwidth expansion
Ultrathin fluid-absorbent cores
Image sensor and method for fabricating the same
Semiconductor apparatus
Method and system for billing based on color component histograms
  Randomly Featured Patents
Rubber compositions for tire inner liners
Error-rate-based laser drive control
Heading hold logic
2-(alkoxy benzothiazolinon-3yl) ethylamines
Static device for air replenishing a liquid product dispenser
N-bit parallel input to variable-bit parallel output shift register
Suspended file holding rack
Pick-up style utility vehicle with expandable cargo bed
Under gravel aquarium filter
Golf shoes